Indian ministries vie for medtech regs control
This article was originally published in Clinica
Two Bills proposing different medical device regulatory reforms are currently being discussed by India's parliament, an industry official has updated Clinica. The Bills are from the Ministry of Health and Family Welfare, favouring a US FDA type of system, and the Ministry of Science and Technology, which favours the EU system. Both ministries want responsibility for the portfolio.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.